Limba
|
Belzutifan (PT2977), an orally active and selective HIF-2αinhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC).
Price | 8.142,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Belzutifan (PT2977), an orally active and selective HIF-2αinhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC). |